CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	12 Months Ended
	Jul. 31, 2016	Jul. 31, 2015
Cash Flows From Operating Activities:
Net Income (loss)	$ (3,223,109)	$ (2,193,358)
Adjustments to reconcile net (loss) / income to net cash used in operating activities:
Depreciation and amortization	265,210	380,680
Common stock issued for services rendered	4,500	133,000
Write-off of patents	1,165,864	320,160
Issuance of stock options as compensation	27,344
Common stock issued for interest on convertible debentures and preferred stock	148,500	156,600
Change in fair value of derivative liabilities	(263,823)	(1,488,237)
Changes in operating assets and liabilities
Accounts payable and accrued expenses	1,056,955	(117,739)
Deferred revenue		(223,662)
Other current assets	43,076	147,820
Net Cash Used in Operating Activities	(775,483)	(2,884,736)
Cash Flows From Investing Activities:
Costs incurred for patents		(90,982)
Net Cash (Used in)/Provided By Investing Activities		(90,982)
Cash Flows From Financing Activities:
Proceeds from issuance of long-term debt	50,000
Proceeds from exercise of stock options	2,952	6,416
Proceeds from issuance of preferred stock, net		475,000
Net Cash Provided by Financing Activities	52,952	481,416
Effect of Exchange Rates on Cash	(10,535)	(25,222)
Net Decrease in Cash and Cash Equivalents	(733,066)	(2,519,524)
Cash and Cash Equivalents, Beginning of Year	749,965	3,269,489
Cash and Cash Equivalents, End of Year	16,899	749,965
Supplemental Disclosure of Cash Flow Information:
Interest paid in cash
Issuance of stock options to satisfy compensation liabilities	$ 123,147